174 related articles for article (PubMed ID: 11081196)
1. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF
Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
3. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
Faglia G; Arosio M; Spada A
Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
[TBL] [Abstract][Full Text] [Related]
4. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
[TBL] [Abstract][Full Text] [Related]
5. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of growth-hormone-secreting human pituitary tumours: biochemical consequences and potential clinical significance.
Adams EF; Buchfelder M; Lei T; Petersen B; Fahlbusch R
Acta Neurochir Suppl; 1996; 65():7-10. PubMed ID: 8738483
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y
Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.
Hamacher C; Bröcker M; Adams EF; Lei T; Fahlbusch R; Buchfelder M; Derwahl M
Pituitary; 1998 Apr; 1(1):13-23. PubMed ID: 11081179
[TBL] [Abstract][Full Text] [Related]
10. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
Johnson MC; Codner E; Eggers M; Mosso L; Rodriguez JA; Cassorla F
J Pediatr Endocrinol Metab; 1999; 12(3):381-7. PubMed ID: 10821217
[TBL] [Abstract][Full Text] [Related]
11. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
12. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
[TBL] [Abstract][Full Text] [Related]
13. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
Adams EF; Lei T; Buchfelder M; Bowers CY; Fahlbusch R
Mol Endocrinol; 1996 Apr; 10(4):432-8. PubMed ID: 8721987
[TBL] [Abstract][Full Text] [Related]
15. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
Mendoza V; Sosa E; Espinosa-de-Los-Monteros AL; Salcedo M; Guinto G; Cheng S; Sandoval C; Mercado M
Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569
[TBL] [Abstract][Full Text] [Related]
16. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
17. TPA enhances growth hormone (GH) secretion effect of GH-releasing hormone (GHRH) by human gsp-positive pituitary somatotrophinomas.
Lei T; Bai X; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1999; 19(3):237-9, 248. PubMed ID: 12840904
[TBL] [Abstract][Full Text] [Related]
18. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity.
Barlier A; Pellegrini-Bouiller I; Gunz G; Zamora AJ; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1999 Aug; 84(8):2759-65. PubMed ID: 10443675
[TBL] [Abstract][Full Text] [Related]
19. Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response.
Goto Y; Kinoshita M; Oshino S; Arita H; Kitamura T; Otsuki M; Shimomura I; Yoshimine T; Saitoh Y
Clin Endocrinol (Oxf); 2014 May; 80(5):714-9. PubMed ID: 24111551
[TBL] [Abstract][Full Text] [Related]
20. Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects.
Plöckinger U; Holst JJ; Messerschmidt D; Hopfenmüller W; Quabbe HJ
Eur J Endocrinol; 1999 Jun; 140(6):538-44. PubMed ID: 10377503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
